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Abstract
Cancer survivorship is being increasingly recognized as an important component of cancer care. This commentary
reviews the key findings reported in the recent BMC Medicine publication of the ACTION study, which focuses on
the health-related quality of life and psychological distress in 5249 cancer survivors in eight low- and middle-
income countries in Southeast Asia. The study identified that more than one-third of survivors experience at least
mild levels of anxiety and depressive symptoms and that poorer outcomes in quality of life, anxiety, and depressive
symptoms are linked to a number of clinical and demographic factors. Such data provides an important foundation
to inform cancer policy and service planning in Asia. Future research efforts are required to further understand the
needs of cancer survivors in this region and determine interventions to improve outcomes for this population.
Please see related article: http://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0768-2.
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Background
Cancer incidence in the Asia-Pacific region accounts for
over 30% of the global worldwide cancer burden [1].
Ongoing efforts to improve cancer services in the
areas of prevention, early detection and screening, and
treatment, have resulted in a growing population of
cancer survivors across the region [2]. Despite major
advances in anti-cancer treatment, improved outcomes
in terms of cure or control of the disease do not
necessarily guarantee a full restoration of health, with
many survivors continuing to experience impaired
quality-of-life as a result of the disease or its treat-
ments. Therefore, cancer survivorship is being increas-
ingly recognized as an important part of cancer care.
There has been limited research to date focusing on
understanding the health needs of cancer survivors
and improving outcomes for this population, especially
in the Asia-Pacific region.
An important step to inform care and policy
In a recent article in BMC Medicine, Kimman et al. [3]
seek to gain an understanding of quality of life and
psychological distress in Asian cancer survivors at
12 months post-diagnosis. The authors measured quality
of life, anxiety, and depressive symptoms in 5249 survivors
in eight low- to middle-income countries (LMICs) using
the European Organisation for Research and Treatment of
Cancer Quality of Life Questionnaire (EORTC QLQ-C30),
the EuroQol-5 dimensions questionnaire, and the Hospital
Anxiety and Depression Scale. Where a formally validated
translated tool was not available, the authors used
the forward-translation and backward-translation World
Health Organization guidelines [4]. Kimman et al. [3]
should be commended for completing this large-scale
international study. Undertaking international studies is
often resource intensive, requiring collaboration with
many investigators and stakeholders, numerous ethics and
local approvals, and protocolized translation of research
instruments.
In addition to documenting the significant health-
related quality of life (HRQoL) and psychological needs
of cancer survivors in the Asia region, the Kimman et al.
[3] study identifies specific groups who are at risk of
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poorer outcomes. That is, the authors identified that
patients with lung cancer and lymphoma had lower level
of global HRQoL as well as higher prevalence of self-
reported anxiety and depressive symptoms. This finding
is not surprising due to a number of known factors that
are associated with increased distress, including the
poorer prognosis and greater symptom burden associ-
ated with lung cancer and the intense nature of treat-
ment of lymphoma. The authors also highlight a number
of other factors significantly associated with a lower level
of quality of life and higher levels of anxiety and depres-
sive symptoms, including being older, being male, having
an advanced stage at diagnosis, being of low-income
status, and not being in paid work. Such findings have
potential implications for health services and clinicians
in their prioritization of care and resources.
This pioneering study provides an important founda-
tion for future work in this region. We make some add-
itional observations for consideration by those with an
interest in advancing cancer services for this popula-
tion. Firstly, HRQoL and psychological distress are key
patient-reported outcomes that should be an important
focus for cancer control efforts. A better understanding
of physical symptom burden of patients beyond those
measured by the EORTC QLQ-C30 is also required.
Moreover, most available data focus on cancer survivors
in the western countries. Future studies could allow for
benchmarking and comparisons between western coun-
tries that have more developed survivorship service
delivery models, high-income Asian countries, and
Asian LMICs. Such comparisons would allow for mean-
ingful benchmarking exercises that can eventually
inform service planning.
Although the study provides useful preliminary find-
ings, the authors themselves acknowledge a number of
key limitations that should be taken into account when
interpreting the results. Of the limitations mentioned by
the authors, one of the most critical is the lack of data
collection and lack of reporting of change scores over
time between diagnosis and at 12 months. Predictive
relationships should only be drawn on a true empirical
basis with the use of longitudinal data [5]. While the
authors provided a rationale for only including data at
12 months, each patient’s quality of life and experience
are uniquely influenced by a number of factors including
their treatment plans. We argue that to provide a more
comprehensive understanding of the multiple influences
on health-related outcomes, it is important to under-
stand changes in outcomes over time taking into ac-
count differences in treatment regimens and pathways.
The study involved combining data from all eight
countries for analysis. We believe that additional in-
sights could also be gained if between-country differ-
ences were reported. There is considerable variation
between countries in health systems, culture, and
resources. Therefore, understanding differences in
health outcomes for cancer survivors between coun-
tries would provide useful data to further examine
how health system, cultural, and resource differences
contribute to differences in outcomes for cancer
survivors.
Kimman et al. [3] provide several useful recommenda-
tions concerning future efforts to improve care provision
and policy development. In order to translate these data
into practice, we suggest the development of consensus
statements and recommendations for minimum stan-
dards for cancer survivorship care provision for coun-
tries in this region. Kimman et al. [3] rightly point out
the lack of resources and poor social economic positions
of the LMICs in this region. Lack of resources and lack
of clarity concerning health professionals’ responsibilities
have been repeatedly identified to be key barriers for de-
livering survivorship interventions [6, 7]. Development
of survivorship care plans and treatment summaries is
highly resource intensive, requiring skilled health profes-
sionals to complete them [7]. It is therefore important
that future research examines the appropriateness and
potential benefits of survivorship care plans and treat-
ment summaries in these countries.
A number of interventions for improving outcomes in
the post-treatment phase have been proposed in the
western context [8–11]. These efforts include a range of
complex interventions comprising survivorship care
plans and follow-up care from designated health profes-
sionals. Despite the largely negative findings in the two
completed trials [8, 11], it is important to continue
efforts to optimize outcomes for cancer survivors
through high quality, culturally appropriate and sus-
tainable survivorship care models [12]. A recent pilot
randomized controlled trial reported that a culturally
adapted psycho-education program was feasible and
potentially effective in improving outcomes in Asian
breast cancer patients [13]. It is important that govern-
ments continue to invest into developing and testing
culturally appropriate, evidence-based service models
and interventions for patients in this region [12].
Conclusions
The ACTION study has made an original, important
contribution to the field by providing an understand-
ing of HRQoL and psychological distress in Asian
cancer survivors. It is important to acknowledge that
this study is a starting point, with much future work
required to further understand and meet the needs of
cancer survivors in the Asia-Pacific region. Cancer
survivorship care is a public health issue, requiring
system-, organizational-, and professional- level re-
sponses. We urge researchers, clinicians, policymakers,
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and healthcare administrators to invest in future efforts
to improve care for the ever-growing population of
cancer survivors.
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